Overall survival among patients with activated phosphoinositide 3-kinase delta syndrome (APDS)

Overall survival among patients with activated phosphoinositide 3-kinase delta syndrome (APDS)

Abstract Background This study aimed to describe overall survival (OS) of patients with APDS relative to the global population as well as among subsets of patients with concurrent lymphoma or hematopoietic stem cell transplant (HSCT) relative to the overall APDS population. Methods Patient-level dat...

Full description

Saved in:
Bibliographic Details
Main Authors: Malena Mahendran, Julia E. M. Upton, Ramya Ramasubramanian, Heidi L. Memmott, Guillaume Germain, Katharina Büsch, François Laliberté, Amanda Harrington
Format: Article
Language:English
Published: BMC 2025-05-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Activated phosphoinositide 3-kinase delta syndrome (APDS)
Hematopoietic stem cell transplant (HSCT)
Inborn error of immunity (IEI)
Lymphoma
Overall survival
Primary immunodeficiency (PID)
Online Access:https://doi.org/10.1186/s13023-025-03734-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13023-025-03734-z

Similar Items